Adelaide Research & Innovation Pty Ltd (External organisation)

Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent

Description

Novel antimicrobial compounds

Abstract: A new class of biotin protein ligase (BPL) inhibitors that have antibacterial activity against multiple Staphylococcus aureus isolates, including clinically important methicillin-resistant S. aureus (MRSA) are disclosed that are non-toxic.

WO2013040647A1 - WIPO (PCT)
Period28 Mar 2013
Held atAdelaide Research & Innovation Pty Ltd, Australia
Degree of RecognitionInternational

Documents & Links